Cigna Group/$CI
1D1W1MYTD1Y5YMAX
Capital at risk
About Cigna Group
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
- Ticker
- $CI
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 66,685
- Headquarters
- Bloomfield, United States
- Website
- www.thecignagroup.com
Cigna Group Metrics
BasicAdvanced
$74B
11.60
$24.18
0.32
$6.14
2.22%
Price and volume
Market cap
$74B
Beta
0.32
52-week high
$315.47
52-week low
$239.51
Average daily volume
1.6M
Dividend rate
$6.14
Financial strength
Current ratio
0.846
Quick ratio
0.687
Long term debt to equity
0.678
Total debt to equity
0.743
Dividend payout ratio (TTM)
25.31%
Interest coverage (TTM)
7.78%
Profitability
EBITDA (TTM)
12,758
Gross margin (TTM)
9.14%
Net profit margin (TTM)
2.27%
Operating margin (TTM)
3.90%
Effective tax rate (TTM)
19.17%
Revenue per employee (TTM)
$4,230,000
Management effectiveness
Return on assets (TTM)
4.46%
Return on equity (TTM)
16.76%
Valuation
Price to earnings (TTM)
11.597
Price to revenue (TTM)
0.262
Price to book
1.74
Price to tangible book (TTM)
-2.48
Price to free cash flow (TTM)
8.122
Free cash flow yield (TTM)
12.31%
Free cash flow per share (TTM)
34.529
Dividend yield (TTM)
2.19%
Forward dividend yield
2.22%
Growth
Revenue change (TTM)
7.77%
Earnings per share change (TTM)
32.61%
3-year revenue growth (CAGR)
14.90%
10-year revenue growth (CAGR)
21.97%
3-year earnings per share growth (CAGR)
3.06%
10-year earnings per share growth (CAGR)
12.11%
3-year dividend per share growth (CAGR)
9.32%
10-year dividend per share growth (CAGR)
65.43%
What the Analysts think about Cigna Group
Analyst ratings (Buy, Hold, Sell) for Cigna Group stock.
Analyst projections of the future price of Cigna Group stock.
Bulls say / Bears say
Cigna beat second-quarter expectations, with revenue up 7% to $71.7bn and adjusted earnings per share of $7.78. It raised its 2026 adjusted EPS outlook to at least $30.45, with both Evernorth and Cigna Healthcare contributing. (The Cigna Group)
Evernorth’s specialty and care business is becoming a stronger growth engine: second-quarter pre-tax earnings rose 22%. Faster uptake of biosimilars and specialty generics, alongside a planned $100m investment in AI-enabled pharmacy operations, could support further efficiency and growth. (Reuters, The Cigna Group)
Cigna is concentrating on employer-sponsored healthcare and pharmacy benefits after deciding to leave the Affordable Care Act exchange market. Its new rebate-free Signature model is attracting early interest, while management says 2027 new-business wins are already unusually strong. (Reuters, Fierce Healthcare)
The shift to Cigna’s rebate-free PBM model is likely to pressure margins during the transition. Management has said the change will squeeze margins for two years, while Evernorth’s second-quarter adjusted profit fell 2% and its pharmacy benefit unit faced renewal and implementation costs. (Reuters, The Cigna Group)
Medical cost pressure remains a risk to insurance margins: Cigna Healthcare’s second-quarter medical care ratio rose to 84.5% from 83.2% a year earlier. The company needed premium increases to cover higher expected costs and still guides to a relatively high 83.7%–84.7% ratio for 2026. (The Cigna Group)
The 2027 earnings outlook is less certain as Cigna exits ACA exchanges and reviews EviCore, while PBM regulation and reduced employer coverage of GLP-1 drugs add further pressure. Jefferies downgraded the shares to Hold and said consensus estimates did not fully reflect these potential earnings gaps. (Investing.com, The Cigna Group)
Data summarised monthly by Lightyear AI. Last updated on 17 Sept 2026.
Cigna Group Financial Performance
Revenues and expenses
Cigna Group Earnings Performance
Company profitability
Upcoming events
Cigna Group News
AllArticlesVideos
Funds containing Cigna Group
AllEURGBPUSD
Fund name | Fund size | $CI weighting |
|---|---|---|
iShares MSCI World Health Care Sector Advanced€CBUF | €606M | 1.58% |
iShares S&P 500 Health Care Sector€IUHE | €125M | 1.26% |
iShares MSCI USA Quality Dividend ESG£HDIQ | £578M | 0.77% |
iShares MSCI USA SRI$SUAS | $3.4B | 0.54% |
iShares MSCI USA SRI€QDVR | €2.9B | 0.54% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.